$60.14-$2.80 (-4.45%)
Global X - Artificial Intelligence & Technology ETF’s quoted price sits in the upper half of its reported 52-week range, 14.4% below the high.
Loading market information…
AMEX · XBI · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
State Street SPDR S&P Biotech ETF’s quoted price sits in the upper half of its reported 52-week range, 8.19% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
State Street SPDR S&P Biotech ETF’s forward annual dividend is $0.28 per share, paid semi-annual. The forward yield is 0.18% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 08:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
KEEP COMPARING
$60.14-$2.80 (-4.45%)
Global X - Artificial Intelligence & Technology ETF’s quoted price sits in the upper half of its reported 52-week range, 14.4% below the high.
$136.12-$2.59 (-1.87%)
JPMorgan BetaBuilders U.S. Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.63% below the high.
$53.84+$0.58 (+1.09%)
First Trust Morningstar Dividend Leaders Index Fund’s quoted price sits in the upper half of its reported 52-week range, 0.63% below the high.
$42.74+$0.03 (+0.07%)
iShares International Select Dividend ETF’s quoted price sits in the upper half of its reported 52-week range, 6.05% below the high.
$42.82-$0.73 (-1.68%)
T. Rowe Capital Appreciation Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 2.3% below the high.
$231.13-$1.91 (-0.82%)
Vanguard S&P 500 Value ETF’s quoted price sits in the upper half of its reported 52-week range, 0.82% below the high.
$32.46-$0.68 (-2.05%)
iShares MSCI Brazil ETF’s quoted price sits in the lower half of its reported 52-week range, 26.06% below the high.
$77.57-$0.79 (-1.01%)
JPMorgan BetaBuilders International Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 5.17% below the high.
